The contents of this announcement, which have been prepared by and are the sole responsibility of QinetiQ, have been approved by Credit Suisse First Boston (Europe) Limited, One Cabot Square, Canary Wharf, London E14 4QJ, JPMorgan Cazenove Limited, 20 Moorgate, London EC2R 6DA and Merrill Lynch International, Merrill Lynch Financial Centre, 2 King Edward Street, London EC1A 1HQ solely for the purposes of section 21(2)(b) of the Financial Services and Markets Act 2000.
Credit Suisse First Boston (Europe) Limited, JPMorgan Cazenove Limited and Merrill Lynch International, each of which are authorised and regulated in the United Kingdom by the FSA, are acting exclusively for QinetiQ, the MOD and the Carlyle Shareholders and no-one else in connection with the Global Offer. They will not regard any other person as their clients in relation to the Global Offer and will not be responsible to anyone other than QinetiQ, the MOD and the Carlyle Shareholders for providing the protections afforded to their respective clients, nor for providing advice in relation to the Global Offer, the contents of this announcement or any transaction, arrangement or other matter referred to herein.
This announcement does not constitute an offer of, or the solicitation of an offer to buy or subscribe for, Ordinary Shares to any person in any jurisdiction to whom or in which such offer or solicitation is unlawful and, in particular, is not for release, publication or distribution in or into the United States, Australia, Canada or Japan.
The offer and sale of the Ordinary Shares has not been and will not be registered under the US Securities Act of 1933, as amended (the "Securities Act") or under the applicable securities laws of Australia, Canada or Japan. Subject to certain exceptions, the Ordinary Shares may not be offered or sold in Australia, Canada, Japan or the United States or to, or for the account or benefit of, any national, resident or citizen of Australia, Canada, Japan or the United States. The Joint Bookrunners may arrange for the offer and sale of Ordinary Shares in the United States only to persons believed to be “qualified institutional buyers” in reliance on Rule 144A under the Securities Act, or another exemption from, or in a transaction not subject to, the registration requirements of the Securities Act. The Ordinary Shares offered and sold outside the United States are being offered in reliance on Regulation S under the Securities Act.
This announcement contains certain "forward-looking statements". In particular, the words "expects", "anticipates", "plans", "intends", "estimates", "may", "should", "believes" and similar expressions can be used to identify forward-looking statements. Certain important factors could cause actual results or outcomes to differ materially from those expressed in forward-looking statements. These statements are based on the QinetiQ directors' expectations of external conditions and events, current strategy, plans and other objectives of management, and estimates and projections of QinetiQ's financial position. Although the directors of QinetiQ believe these expectations to be reasonable at the date of this announcement, they may prove to be erroneous. Forward-looking statements involve known and unknown risks and uncertainties and speak only as of the date they are made. Investors are cautioned that certain important factors could cause actual results or outcomes to differ materially from those expressed in forward-looking statements.
This announcement does not constitute a recommendation concerning the Global Offer. The value of shares can go down as well as up. Past performance is not a guide to future performance. Potential investors should consult a professional advisor as to the suitability of the Global Offer for the individual concerned. |